BRPI0416702A2 - Formulação purgativa colônica, kit, métodos de purgar o cólon de um paciente, de tratar um paciente com, ou suscetível a, um distúrbio gastrointestinal, e de tratar um paciente sofrendo de, ou suscetível à, constipação, e, processo de produzir a formulação purgativa colônica - Google Patents
Formulação purgativa colônica, kit, métodos de purgar o cólon de um paciente, de tratar um paciente com, ou suscetível a, um distúrbio gastrointestinal, e de tratar um paciente sofrendo de, ou suscetível à, constipação, e, processo de produzir a formulação purgativa colônicaInfo
- Publication number
- BRPI0416702A2 BRPI0416702A2 BRPI0416702-3A2A BRPI0416702A BRPI0416702A2 BR PI0416702 A2 BRPI0416702 A2 BR PI0416702A2 BR PI0416702 A BRPI0416702 A BR PI0416702A BR PI0416702 A2 BRPI0416702 A2 BR PI0416702A2
- Authority
- BR
- Brazil
- Prior art keywords
- patient
- suspectable
- treating
- colonic
- proceduring
- Prior art date
Links
- 230000000112 colonic effect Effects 0.000 title 2
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- 210000001072 colon Anatomy 0.000 title 1
- 208000010643 digestive system disease Diseases 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 208000018685 gastrointestinal system disease Diseases 0.000 title 1
- 239000008141 laxative Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001543 purgative effect Effects 0.000 title 1
- 238000010926 purge Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR122014001142A BR122014001142B8 (pt) | 2003-11-19 | 2004-11-17 | processo de produzir uma formulação em comprimido purgativa colônica para administração oral |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52314203P | 2003-11-19 | 2003-11-19 | |
US60/523142 | 2003-11-19 | ||
PCT/US2004/038220 WO2005051361A1 (en) | 2003-11-19 | 2004-11-17 | Colonic purgative composition with soluble binding agent |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI0416702A2 true BRPI0416702A2 (pt) | 2015-01-27 |
BRPI0416702A8 BRPI0416702A8 (pt) | 2020-09-24 |
BRPI0416702B1 BRPI0416702B1 (pt) | 2020-10-20 |
BRPI0416702B8 BRPI0416702B8 (pt) | 2022-08-23 |
Family
ID=34632758
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0416702A BRPI0416702B8 (pt) | 2003-11-19 | 2004-11-17 | formulação purgativa colônica em uma forma de dosagem sólida para administração oral, e, kit |
BR122014001142A BR122014001142B8 (pt) | 2003-11-19 | 2004-11-17 | processo de produzir uma formulação em comprimido purgativa colônica para administração oral |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122014001142A BR122014001142B8 (pt) | 2003-11-19 | 2004-11-17 | processo de produzir uma formulação em comprimido purgativa colônica para administração oral |
Country Status (12)
Country | Link |
---|---|
US (3) | US7687075B2 (pt) |
EP (2) | EP1682098B1 (pt) |
JP (3) | JP5329042B2 (pt) |
KR (4) | KR101323628B1 (pt) |
CN (2) | CN101087593B (pt) |
AR (1) | AR046651A1 (pt) |
AU (2) | AU2004292428B2 (pt) |
BR (2) | BRPI0416702B8 (pt) |
CA (2) | CA2814523C (pt) |
ES (1) | ES2584866T3 (pt) |
PL (1) | PL1682098T3 (pt) |
WO (1) | WO2005051361A1 (pt) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0224909D0 (en) * | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
US7687075B2 (en) | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
GB0409104D0 (en) * | 2004-04-23 | 2004-05-26 | Norgine Europe Bv | Compressed pharmaceutical compositions |
AU2005320935B2 (en) * | 2004-12-30 | 2012-02-16 | Given Imaging Ltd. | Device, system and method for in-vivo examination |
EP1877039A4 (en) * | 2005-05-06 | 2010-08-18 | Salix Pharmaceuticals Inc | Polyethylene glycol GUT CLEANING COMPOSITION |
AU2013202513B2 (en) * | 2005-05-06 | 2016-03-24 | Salix Pharmaceuticals, Inc. | Polyethylene glycol colonic purgative composition |
CN1748675A (zh) * | 2005-07-11 | 2006-03-22 | 丛晓东 | 大黄酸类化合物的复合物及制备方法与治疗糖尿病的应用 |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
WO2007118226A2 (en) * | 2006-04-07 | 2007-10-18 | Sunten Phytotech Co., Ltd. | Anthracenedione compounds |
DE102006017672B4 (de) * | 2006-04-12 | 2008-07-03 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Zusammensetzung zur Verwendung als Laxativum |
ES2292345B1 (es) * | 2006-05-12 | 2009-02-16 | Madaus, S.A. | "uso, composicion y preparacion farmaceutica de plantago ovata". |
DE102007023397B4 (de) * | 2007-05-02 | 2015-03-26 | Madaus Gmbh | Neue pharmazeutische Zusammensetzung zur Verwendung als Laxativum |
AU2008254999A1 (en) * | 2007-05-17 | 2008-11-27 | Theravance, Inc. | Prokinetic agent for bowel preparation |
AU2008253583A1 (en) * | 2007-05-17 | 2008-11-27 | David Lubowski | Combination laxative compositions comprising a colonic stimulant and a bulking laxative |
CN101450049A (zh) * | 2007-12-07 | 2009-06-10 | 辉凌国际制药(瑞士)有限公司 | 药物组合物 |
DK2294012T3 (da) * | 2008-05-07 | 2014-10-06 | Salix Pharmaceuticals Ltd | Administration af et tarmrensemiddel og et antibiotika til behandlingen af tarmsygdom |
WO2010005965A1 (en) * | 2008-07-08 | 2010-01-14 | Aronchick Craig A | Colonic purgative formulations and methods of using the same |
KR101053731B1 (ko) * | 2008-10-21 | 2011-08-02 | 이문성 | 용해시간 조절형 장세척제 조성물의 제조방법 |
US20100178360A1 (en) * | 2009-01-13 | 2010-07-15 | Universite Libre De Bruxelles | Nutritive composition |
NZ595346A (en) * | 2009-03-27 | 2014-12-24 | Salix Pharmaceuticals Ltd | Compositions for bowel preparation and methods of use thereof |
WO2010123901A1 (en) | 2009-04-21 | 2010-10-28 | Bachwich Dale R | Colon lavage system |
CN101874796A (zh) * | 2009-04-29 | 2010-11-03 | 田普森 | 一种治疗便秘的药物制剂及其制备方法 |
EP2657243A1 (en) * | 2009-06-03 | 2013-10-30 | Aptalis Pharma Canada, Inc. | L-Sugar Colon Cleansing Agent and Uses Thereof |
CA2765033C (en) | 2009-06-12 | 2020-07-14 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
US20110021591A1 (en) * | 2009-07-21 | 2011-01-27 | Gordon Douglas J | Phenylbutazone carrier formulation showing increased bioactivity in animals |
TW201113366A (en) * | 2009-08-31 | 2011-04-16 | Zeria Pharm Co Ltd | Orally administrable tablet for intestinal lavage |
US9040095B2 (en) * | 2009-10-14 | 2015-05-26 | Gi Innovations, Pllc | Colon cleansing of residual stool and secretions during colonoscopy |
AU2010312309B2 (en) | 2009-10-26 | 2016-10-06 | Thomas Julius Borody | Novel enteric combination therapy |
CN102283861A (zh) * | 2010-06-17 | 2011-12-21 | 杭州赛利药物研究所有限公司 | 氢氧化镁在制药中的用途以及氢氧化镁制剂和制备方法 |
JP6121334B2 (ja) * | 2010-12-13 | 2017-04-26 | サリックス ファーマシューティカルズ,インコーポレイテッド | 胃および結腸製剤ならびにそれらを作製するための方法および使用するための方法 |
JP5870119B2 (ja) | 2011-01-28 | 2016-02-24 | ブレインツリー ラボラトリーズ、インク. | 腸洗浄のための、方法、組成物、およびパッケージ |
TWI535461B (zh) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
US8778907B2 (en) | 2011-04-27 | 2014-07-15 | Cumberland Pharmaceuticals | Lactulose for bowel evacuation |
CN102178694B (zh) * | 2011-05-06 | 2013-03-20 | 四川健能制药有限公司 | 磷酸钠盐液体制剂 |
JP5842521B2 (ja) * | 2011-09-30 | 2016-01-13 | ゼリア新薬工業株式会社 | 便秘改善薬 |
US20150056140A1 (en) * | 2011-10-27 | 2015-02-26 | Thomas Julius Borody | Electrolyte purgatives |
RU2473330C1 (ru) * | 2011-12-09 | 2013-01-27 | Александр Павлович Погромов | Средство для кишечного лаважа |
NZ704014A (en) * | 2012-07-27 | 2017-10-27 | Redhill Biopharma Ltd | Formulations and methods of manufacturing formulations for use in colonic evacuation |
CA3116204C (en) | 2012-09-11 | 2023-09-12 | Norgine Bv | Colon cleansing composition comprising ascorbate and peg |
RS59667B1 (sr) | 2013-03-15 | 2020-01-31 | Braintree Laboratories Inc | Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe |
JP2014224080A (ja) * | 2013-05-17 | 2014-12-04 | 協和化学工業株式会社 | 大腸の検査または手術のための処置剤 |
CN103585173B (zh) * | 2013-10-28 | 2016-06-29 | 王显著 | 含硫酸钠和匹可硫酸的药物组合物 |
KR101659746B1 (ko) | 2014-01-28 | 2016-09-26 | 주식회사한국파마 | 황산염을 함유하는 장관 하제 조성물 및 이의 제조 방법 |
EA201692106A1 (ru) | 2014-04-29 | 2017-04-28 | КОЛОНАРИКОНСЕПТС ЭлЭлСи | Пищевые продукты, системы, способы и наборы для замены электролитов |
AU2016226380A1 (en) | 2015-03-02 | 2017-09-21 | Colonaryconcepts Llc | Compounds and methods for PEG metabolite and PEG breakdown product assays |
US20180318234A1 (en) * | 2015-06-22 | 2018-11-08 | Ctc Bio, Inc. | Purgative composition for cleansing intestinal tract |
WO2017011430A1 (en) * | 2015-07-13 | 2017-01-19 | Halow George M | Bowel cleansing compositions and methods |
WO2017131461A1 (ko) * | 2016-01-28 | 2017-08-03 | 주식회사 씨티씨바이오 | 하제 조성물 |
JP2018131396A (ja) * | 2017-02-14 | 2018-08-23 | 学校法人自治医科大学 | 経口腸管洗浄剤および大腸カプセル内視鏡用ブースター |
US10143656B1 (en) | 2017-08-04 | 2018-12-04 | Braintree Laboratories, Inc. | Solid oral sulfate salt formulations for cleaning a colon and methods of using same |
KR102005072B1 (ko) * | 2017-12-15 | 2019-07-29 | 주식회사 씨티씨바이오 | 장관 세척용 하제 조성물 |
KR102111094B1 (ko) | 2018-06-18 | 2020-05-14 | 주식회사 한국팜비오 | 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물 |
CN112386577B (zh) * | 2019-08-16 | 2024-01-23 | 北京天衡药物研究院有限公司 | 一种治疗便秘的组合物 |
CN112587498A (zh) * | 2020-12-29 | 2021-04-02 | 哈尔滨瀚钧现代制药有限公司 | 多库酯钠丹蒽醌及其制备方法 |
CN115040512B (zh) * | 2022-07-28 | 2023-06-20 | 苏州中化药品工业有限公司 | 一种药物组合物及其制备方法 |
WO2024149252A1 (zh) * | 2023-01-09 | 2024-07-18 | 上海石趣医药科技有限公司 | 磷酸镁物质、包含其的药物组合物及其用途 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3121663A (en) | 1956-02-09 | 1964-02-18 | Plough Lab Inc | Carbon dioxide releasing laxative suppository |
US3202578A (en) | 1957-09-27 | 1965-08-24 | Elder Paul B Co | Polymeric laxative composition and method of using same |
GB1459488A (en) | 1974-03-19 | 1976-12-22 | Wyeth John & Brother Ltd | Piperazinedione derivatives |
US4321263A (en) | 1980-09-30 | 1982-03-23 | Rowell Laboratories, Inc. | Psyllium compositions |
US4812311A (en) | 1984-12-21 | 1989-03-14 | The Procter & Gamble Company | Kit for use in the treatment of osteoporosis |
WO1987000754A1 (en) | 1985-08-01 | 1987-02-12 | Braintree Laboratories, Inc. | Low-sodium laxative and lavage formulation |
US4849227A (en) * | 1986-03-21 | 1989-07-18 | Eurasiam Laboratories, Inc. | Pharmaceutical compositions |
US4828842A (en) | 1986-09-16 | 1989-05-09 | L. Perrigo Company | Water dispersible compound |
US4999200A (en) | 1987-12-09 | 1991-03-12 | Marion Laboratories | Psyllium tablet composition, method of manufacture and method of use |
JPH0816061B2 (ja) | 1988-07-13 | 1996-02-21 | 森下ルセル株式会社 | 腸管洗浄液用組成物と腸管洗浄液 |
US5294451A (en) * | 1991-03-29 | 1994-03-15 | Curtice-Burns, Inc. | Fat substitute compositions having reduced laxative effects |
US5397573A (en) * | 1993-06-04 | 1995-03-14 | The Procter & Gamble Company | Laxative compositions |
US5516524A (en) | 1993-12-20 | 1996-05-14 | The Procter & Gamble Company | Laxative compositions containing bulk fiber |
US5498425A (en) * | 1995-03-17 | 1996-03-12 | Block Drug Company, Inc. | Phosphosoda buffered saline laxative |
US5710183A (en) | 1995-07-14 | 1998-01-20 | Halow; George M. | Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent |
FR2746643B1 (fr) * | 1996-04-01 | 1998-06-12 | Techni Pharma | Nouvelles compositions laxatives et leur procede de fabrication |
DE69627170T2 (de) | 1996-05-08 | 2004-03-04 | Aronchick, Graig A. | Nichtwässrige abführmittel für den kolon |
AU731016B2 (en) | 1996-11-13 | 2001-03-22 | C.B. Fleet Company Incorporated | A coated sodium phosphate bowel cleanser |
US6162464A (en) | 1997-03-31 | 2000-12-19 | Inkine Pharmaceutical, Inc. | Non-aqueous colonic purgative formulations |
US6048901A (en) | 1999-04-20 | 2000-04-11 | Braintree Laboratories, Inc. | Method of reducing intestinal gas, cramping and anorectal irritation |
US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
US6645481B1 (en) | 2000-09-28 | 2003-11-11 | Braintree Laboratories, Inc. | Method of achieving overnight laxation and control of bowel function |
US6946149B2 (en) | 2002-04-30 | 2005-09-20 | Braintree Laboratories, Inc. | Salt solution for colon cleansing |
US8361452B2 (en) | 2002-07-15 | 2013-01-29 | Halow George M | Bowel cleansing composition |
US20040071779A1 (en) | 2002-10-09 | 2004-04-15 | Keiser Dale Arthur | Gelled laxative compositions |
US7687075B2 (en) | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
-
2004
- 2004-11-16 US US10/988,693 patent/US7687075B2/en active Active
- 2004-11-17 JP JP2006541302A patent/JP5329042B2/ja active Active
- 2004-11-17 AU AU2004292428A patent/AU2004292428B2/en not_active Ceased
- 2004-11-17 WO PCT/US2004/038220 patent/WO2005051361A1/en active Application Filing
- 2004-11-17 BR BRPI0416702A patent/BRPI0416702B8/pt active IP Right Grant
- 2004-11-17 KR KR1020127003801A patent/KR101323628B1/ko active IP Right Grant
- 2004-11-17 EP EP04819530.9A patent/EP1682098B1/en active Active
- 2004-11-17 PL PL04819530.9T patent/PL1682098T3/pl unknown
- 2004-11-17 EP EP10180972.1A patent/EP2308476B1/en active Active
- 2004-11-17 CN CN2004800407012A patent/CN101087593B/zh active Active
- 2004-11-17 KR KR1020117019045A patent/KR101268559B1/ko active IP Right Grant
- 2004-11-17 BR BR122014001142A patent/BR122014001142B8/pt active IP Right Grant
- 2004-11-17 CA CA2814523A patent/CA2814523C/en active Active
- 2004-11-17 ES ES04819530.9T patent/ES2584866T3/es active Active
- 2004-11-17 KR KR1020067011762A patent/KR20060114342A/ko not_active Application Discontinuation
- 2004-11-17 KR KR1020137007695A patent/KR101495690B1/ko active IP Right Grant
- 2004-11-17 CA CA2546637A patent/CA2546637C/en active Active
- 2004-11-17 CN CN201210119344.5A patent/CN102648980B/zh active Active
- 2004-11-19 AR ARP040104289A patent/AR046651A1/es not_active Application Discontinuation
-
2008
- 2008-03-13 US US12/075,772 patent/US7718197B2/en active Active
-
2010
- 2010-01-20 US US12/690,384 patent/US8507009B2/en active Active
-
2011
- 2011-05-20 AU AU2011202346A patent/AU2011202346B2/en not_active Ceased
- 2011-06-14 JP JP2011132713A patent/JP5502807B2/ja active Active
-
2014
- 2014-01-17 JP JP2014007066A patent/JP2014065746A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0416702A2 (pt) | Formulação purgativa colônica, kit, métodos de purgar o cólon de um paciente, de tratar um paciente com, ou suscetível a, um distúrbio gastrointestinal, e de tratar um paciente sofrendo de, ou suscetível à, constipação, e, processo de produzir a formulação purgativa colônica | |
NO20054640D0 (no) | Fremgangsmater for behandling av Parkinsons sykdom | |
DK1443955T3 (da) | PDGF-BB til behandling af Parkinsons sygdom | |
DE60237823D1 (de) | Medizinisches behandlungsinstrument | |
DK1392287T3 (da) | Anvendelse af substituerede azetidinonderivater i behandlingen af Alzheimers sygdom | |
CY1116256T1 (el) | Il-17 ανταγωνιστικα αντισωματα | |
DK1765388T3 (da) | Kombinationsterapi til forebyggelse eller behandling af alzheimer's sygdom, og kit dertil | |
CY2015017I1 (el) | Ενωσεις 1,2,4-οξαδιαζολο βενζοϊκου οξεος και χρηση αυτων για μη νοηματικη καταστολη και τη θεραπεια ασθενειας | |
EP1817050A4 (en) | DIAGNOSIS AND TREATMENT OF MORBUS ALZHEIMER | |
CY2014037I2 (el) | C-met διαμορφωτες και μεθοδοι χρησης | |
EE200200716A (et) | Ühendid Alzheimeri tõve käitluseks | |
IL231857A (en) | A method for diagnosing and assessing Alzheimer's disease in a patient suspected of having this disease | |
FR2857200B1 (fr) | Processeur video pour l'endoscopie | |
AU2003220096A1 (en) | Methods for alzheimer's disease treatment and cognitive enhancement | |
DK1623228T3 (da) | Aopciii og behandling og diagnose af diabetes | |
EE200300216A (et) | Radiofarmatseutilised ained Alzheimeri tõve diagnoosimiseks | |
HUP0302478A2 (hu) | Modafinil-vegyületek gyógyszerészeti oldatai | |
NO20040659L (no) | Isoksazolopyridinoner og andvendelse derav ved behandling av Parkinsons sykdom | |
FR2845267B1 (fr) | Kit cutane de diagnostic de l'atopie | |
NO20042476L (no) | Anvendelse av desoxypeganin for behandling av klinisk depresjon | |
FR2874855B1 (fr) | Instrument d'ecriture | |
AU2003236714A8 (en) | Diagnosis of alzheimer's disease based on the habeta42:habeta40 ratio | |
FR2828212B1 (fr) | Methodes de diagnostic et de pronostic de la maladie de parkinson | |
FR2850732B1 (fr) | Organe d'arret d'une glace dans le corps d'un appareil d'eclairage | |
FR2829620B1 (fr) | Filtre en guide d'ondes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11Z | Dismissal: petition dismissal - article 216, par 2 of industrial property law |
Free format text: REFERENTE A PETICAO 020060070989/RJ DE 18/05/2006. |
|
B12F | Other appeals [chapter 12.6 patent gazette] | ||
B11M | Decision cancelled [chapter 11.13 patent gazette] |
Free format text: EM ATENDIMENTO A DECISAO RECURSAL PUBLICADA NA RPI 2229, FOI REFORMADO O ARQUIVAMENTO DA PETICAO NO 020060070989 DE 18/05/2006. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B25C | Requirement related to requested transfer of rights |
Owner name: SALIX PHARMACEUTICALS, INC. (US) Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 20060106934 DE 17/07/2006, E NECESSARIO APRESENTAR O DOCUMENTO DEVIDAMENTE NOTARIZADO E COM APOSTILAMENTO OU LEGALIZACAO CONSULAR, TRADUCAO JURAMENTADA DO MESMO, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
B25B | Requested transfer of rights rejected |
Owner name: SALIX PHARMACEUTICALS, INC. (US) Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 20060106934 DE 17/07/2006, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2512, DE 26/02/2019. |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/11/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B15V | Prolongation of time limit allowed | ||
B25A | Requested transfer of rights approved |
Owner name: SALIX PHARMACEUTICALS, INC. (US) |